CLINICAL_TRIALS
research
· 2015-09-28
Clinical Trial Update: Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions
Summary
Clinical trial update on using the Mespere Venus 1000 device to predict hospital readmissions in patients with acute decompensated heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mespere Lifesciences Inc. | Conditions: ADHF | Status: UNKNOWN